Evidence map›Paper›PMID 32977809›Full record

ArticleMalaria journal2020

Mass radical treatment of a group of foreign workers to mitigate the risk of re-establishment of malaria in Sri Lanka.

Manonath M Marasinghe, Vissundara M Karunasena, Arundika S Seneratne, Hema D B Herath, Deepika Fernando, Rajitha Wickremasinghe, Kamini N Mendis, Dewanee Ranaweera

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 3 pooled it
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 3 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Malaria Control, Elimination, and Prevention as Components of Health Security: A Review.The American journal of tropical medicine and hygiene · 2022
    Pooled it
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Manonath M MarasingheAnti Malaria Campaign, Colombo, Sri Lanka.
Vissundara M KarunasenaRegional Malaria Office, Moneragala, Sri Lanka.
Arundika S SeneratneAnti Malaria Campaign, Colombo, Sri Lanka.
Hema D B HerathAnti Malaria Campaign, Colombo, Sri Lanka.
Deepika FernandoDepartment of Parasitology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka. deepika@parasit.cmb.ac.lk.
Rajitha WickremasingheDepartment of Public Health, Faculty of Medicine, University of Kelaniya, Colombo, Sri Lanka.
Kamini N Mendis, 141, Jawatta Road, Colombo 5, Sri Lanka.
Dewanee RanaweeraAnti Malaria Campaign, Colombo, Sri Lanka.
Anti Filariasis Campaign · LKUniversity of Colombo · LKUniversity of Kelaniya · LK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFollowing malaria elimination, Sri Lanka was free from indigenous transmission for six consecutive years, until the first introduced case was reported in December 2018. The source of transmission (index case) was a member of a group of 32 migrant workers from India and the location of transmission was their residence reporting a high prevalence of the primary vector for malaria. Despite extensive vector control the situation was highly susceptible to onward transmission if another of the group developed malaria. Therefore, Mass Radical Treatment (MRT) of the group of workers for Plasmodium vivax malaria was undertaken to mitigate this risk.

methodThe workers were screened for malaria by microscopy and RDT, their haemoglobin level assessed, and tested for Glucose 6 phosphate dehydrogenase deficiency (G6PD) using the Care Start RDT and Brewers test prior to treatment with chloroquine (CQ) 25 mg/kg body weight (over three days) and primaquine (PQ) (0.25 mg/kg/day bodyweight for 14 days) following informed consent. All were monitored for adverse events.

resultsNone of the foreign workers were parasitaemic at baseline screening and their haemoglobin levels ranged from 9.7-14.7 g/dl. All 31 individuals (excluding the index case treated previously) were treated with the recommended dose of CQ. The G6PD test results were inconclusive in 45% of the RDT results and were discrepant between the two tests in 31% of the remaining test events. Seven workers who tested G6PD deficient in either test were excluded from PQ and the rest, 24 workers, received PQ. No serious adverse events occurred.

conclusionsMass treatment may be an option in prevention of reintroduction settings for groups of migrants who are likely to be carrying latent malaria infections, and resident in areas of high receptivity. However, in the case of Plasmodium vivax and Plasmodium ovale, a more reliable and affordable point-of-care test for G6PD activity would be required. Most countries which are eliminating malaria now are in the tropical zone and face considerable and similar risks of malaria re-introduction due to massive labour migration between them and neighbouring countries. Regional elimination of malaria should be the focus of global strategy if malaria elimination from countries is to be worthwhile and sustainable.

Indexed as

AntimalarialsChloroquineHumansIndiaMalaria, VivaxMass Drug AdministrationPlasmodium vivaxPrimaquineSri LankaAntimalarialsChloroquinePrimaquineG6PDMalariaMass radical treatmentMigrant labourPrevention of reintroduction

Identifiers

PMID32977809
PMCPMC7517794
OpenAlexW3088320152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.